ArrestinDb

cariprazine

Agent/drug
Bioactivity

cariprazine

SMILES	CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
InChIKey	KPWSJANDNDDRMB-QAQDUYKDSA-N

Chemical Properties

Hydrogen bond acceptors	3
Hydrogen bond donors	1
Rotatable bonds	5
Molecular weight (Da)	426.2

Database connections

PubChem Guide To Pharmacology ChEMBL_compound_ids Drug Central DrugBank ChEMBL_compound_ids PubChem GPCRdb
Structure pdb	7VOD
Ligand site mutations	5-HT_2A D₂

Search:

Receptor					Activity				Source

Protein	Gene	Species	Family	Class	Type	Min	Avg	Max	Database

α_1A	ADA1A	Human	Adrenoceptors	A	pKi	6.62	6.62	6.62	ChEMBL
α_1B	ADA1B	Human	Adrenoceptors	A	pKi	5.71	5.71	5.71	ChEMBL
α_1D	ADA1D	Human	Adrenoceptors	A	pKi	6.49	6.49	6.49	ChEMBL
α_1D	ADA1D	Human	Adrenoceptors	A	pKi	8.18	8.18	8.18	Drug Central
α_2A	ADA2A	Human	Adrenoceptors	A	pKi	5.76	5.76	5.76	ChEMBL
α_2B	ADA2B	Human	Adrenoceptors	A	pKi	5.96	5.96	5.96	ChEMBL
α_2C	ADA2C	Human	Adrenoceptors	A	pKi	6.63	6.63	6.63	ChEMBL
β₁	ADRB1	Human	Adrenoceptors	A	pKi	6.65	6.65	6.65	ChEMBL
5-HT_1A	5HT1A	Human	5-Hydroxytryptamine	A	pKi	7.27	8.38	8.74	ChEMBL
5-HT_1A	5HT1A	Human	5-Hydroxytryptamine	A	pKi	8.07	8.07	8.07	Drug Central
5-HT_1B	5HT1B	Human	5-Hydroxytryptamine	A	pKi	6.89	6.89	6.89	ChEMBL
5-HT_1D	5HT1D	Human	5-Hydroxytryptamine	A	pKi	7.11	7.11	7.11	ChEMBL
5-HT_2A	5HT2A	Human	5-Hydroxytryptamine	A	pKi	6.25	7.24	7.73	ChEMBL
5-HT_2A	5HT2A	Human	5-Hydroxytryptamine	A	pKi	8.11	8.11	8.11	Drug Central
5-HT_2B	5HT2B	Human	5-Hydroxytryptamine	A	pKi	8.03	8.03	8.03	Drug Central
5-HT_2B	5HT2B	Human	5-Hydroxytryptamine	A	pKi	9.82	9.82	9.82	ChEMBL
5-HT_2C	5HT2C	Human	5-Hydroxytryptamine	A	pKi	5.90	6.49	6.70	ChEMBL
5-HT_2C	5HT2C	Human	5-Hydroxytryptamine	A	pKi	8.16	8.16	8.16	Drug Central
5-HT_5A	5HT5A	Human	5-Hydroxytryptamine	A	pKi	5.48	5.48	5.48	ChEMBL
5-HT₆	5HT6R	Human	5-Hydroxytryptamine	A	pKi	5.89	5.89	5.89	ChEMBL

Showing 1 to 20 of 38 entries

Search:

Receptor					Activity				Source

Protein	Gene	Species	Family	Class	Type	Min	Avg	Max	Database

D₂	DRD2	Human	Dopamine	A	pEC50	6.95	8.64	9.74	ChEMBL
D₂	DRD2	Human	Dopamine	A	pIC50	8.77	8.77	8.78	ChEMBL
D₂	DRD2	Rat	Dopamine	A	pIC50	8.11	8.11	8.11	Drug Central
D₂	DRD2	Rat	Dopamine	A	pIC50	7.80	7.80	7.80	ChEMBL
D₃	DRD3	Human	Dopamine	A	pEC50	8.24	8.48	8.72	ChEMBL
D₃	DRD3	Human	Dopamine	A	pIC50	8.70	8.70	8.70	ChEMBL
D₃	DRD3	Rat	Dopamine	A	pIC50	8.06	8.06	8.06	Drug Central
D₃	DRD3	Rat	Dopamine	A	pIC50	8.80	8.80	8.80	ChEMBL

Showing 1 to 8 of 8 entries

cariprazine

Drug properties

Molecular type	Small molecule
Physiological/Surrogate	Surrogate
Approved drug	Yes

Clinical Trials

Phase I 0

Phase II 5

Phase III 8

Approved Yes

Database connections

PubChem Guide To Pharmacology ChEMBL_compound_ids Drug Central DrugBank ChEMBL_compound_ids PubChem GPCRdb
Structure pdb	7VOD
Ligand site mutations	5-HT_2A D₂

Sankey plot

Drug Information

Search:

Target					Disease				Phase

Gene	Protein	Receptor family	Ligand type	Class	Indication name	ICD11	ATC	Association score	Phase	Approved

5HT1A	5-HT_1A receptor	5-Hydroxytryptamine receptors	Aminergic receptors	Class A	Autism spectrum disorder, unspecified	6A02.Z	N05A	0.451	3	Yes
5HT1A	5-HT_1A receptor	5-Hydroxytryptamine receptors	Aminergic receptors	Class A	Bipolar type I disorder, unspecified	6A60.Z	N05A	0.591	4	Yes
5HT1A	5-HT_1A receptor	5-Hydroxytryptamine receptors	Aminergic receptors	Class A	Depressive disorders, unspecified	6A7Z	N05A	0.596	4	Yes
5HT1A	5-HT_1A receptor	5-Hydroxytryptamine receptors	Aminergic receptors	Class A	Generalised anxiety disorder	6B00	N05A	0.543	2	Yes
5HT1A	5-HT_1A receptor	5-Hydroxytryptamine receptors	Aminergic receptors	Class A	Schizophrenia, episode unspecified	6A20.Z	N05A	0.622	4	Yes
5HT1A	5-HT_1A receptor	5-Hydroxytryptamine receptors	Aminergic receptors	Class A	Single episode depressive disorder, severe, without psychotic symptoms	6A70.3	N05A	0.634	4	Yes
5HT2A	5-HT_2A receptor	5-Hydroxytryptamine receptors	Aminergic receptors	Class A	Autism spectrum disorder, unspecified	6A02.Z	N05A	0.462	3	Yes
5HT2A	5-HT_2A receptor	5-Hydroxytryptamine receptors	Aminergic receptors	Class A	Bipolar type I disorder, unspecified	6A60.Z	N05A	0.609	4	Yes
5HT2A	5-HT_2A receptor	5-Hydroxytryptamine receptors	Aminergic receptors	Class A	Depressive disorders, unspecified	6A7Z	N05A	0.607	4	Yes
5HT2A	5-HT_2A receptor	5-Hydroxytryptamine receptors	Aminergic receptors	Class A	Generalised anxiety disorder	6B00	N05A	0.392	2	Yes
5HT2A	5-HT_2A receptor	5-Hydroxytryptamine receptors	Aminergic receptors	Class A	Schizophrenia, episode unspecified	6A20.Z	N05A	0.620	4	Yes
5HT2A	5-HT_2A receptor	5-Hydroxytryptamine receptors	Aminergic receptors	Class A	Single episode depressive disorder, severe, without psychotic symptoms	6A70.3	N05A	0.632	4	Yes
5HT2B	5-HT_2B receptor	5-Hydroxytryptamine receptors	Aminergic receptors	Class A	Bipolar type I disorder, unspecified	6A60.Z	N05A	0.074	4	Yes
5HT2B	5-HT_2B receptor	5-Hydroxytryptamine receptors	Aminergic receptors	Class A	Depressive disorders, unspecified	6A7Z	N05A	0.448	4	Yes
5HT2B	5-HT_2B receptor	5-Hydroxytryptamine receptors	Aminergic receptors	Class A	Schizophrenia, episode unspecified	6A20.Z	N05A	0.591	4	Yes
5HT2B	5-HT_2B receptor	5-Hydroxytryptamine receptors	Aminergic receptors	Class A	Single episode depressive disorder, severe, without psychotic symptoms	6A70.3	N05A	0.050	4	Yes
DRD2	D₂ receptor	Dopamine receptors	Aminergic receptors	Class A	Autism spectrum disorder, unspecified	6A02.Z	N05A	0.499	3	Yes
DRD2	D₂ receptor	Dopamine receptors	Aminergic receptors	Class A	Bipolar type I disorder, unspecified	6A60.Z	N05A	0.660	4	Yes
DRD2	D₂ receptor	Dopamine receptors	Aminergic receptors	Class A	Depressive disorders, unspecified	6A7Z	N05A	0.655	4	Yes
DRD2	D₂ receptor	Dopamine receptors	Aminergic receptors	Class A	Generalised anxiety disorder	6B00	N05A	0.391	2	Yes

Showing 1 to 20 of 28 entries

Join us

Cite us

Main reference

cariprazine

cariprazine

Chemical Properties

Database connections

Bioactivities

cariprazine

Drug properties

Clinical Trials

Database connections

Sankey plot

Drug Information